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Background: Although tobacco mosaic virus (TMV) coat protein (CP) has been isolated from virus particles and its
crystals have grown in ammonium sulfate buffers for many years, to date, no one has reported on the
crystallization of recombinant TMV-CP connecting peptides expressed in E. coli.
Methods: In the present papers genetically engineered TMV-CP was expressed, into which hexahistidine (His) tags
or glutathione-S-transferase (GST) tags were incorporated. Considering that GST-tags are long peptides and His-tags
are short peptides, an attempt was made to grow crystals of TMV-CP cleaved GST-tags (WT-TMV-CP32) and TMV-CP
incorporated His-tags (WT-His-TMV-CP12) simultaneously in ammonium sulfate buffers and commercial crystallization
reagents. It was found that the 20S disk form of WT-TMV-CP32 and WT-His-TMV-CP12 did not form high resolution
crystals by using various crystallization buffers and commercial crystallization reagents. Subsequently, a new
experimental method was adopted in which a range of truncated TMV-CP was constructed by removing several
amino acids from the N- or the C-terminal, and high resolution crystals were grown in ammonium sulfate buffers
and commercial crystallization reagents.
Results: The new crystallization method was developed and 3.0 Å resolution macromolecular crystal was thereby
obtained by removing four amino acids at the C-terminal of His-TMV-CP and connecting six His-tags at the
N-terminal of His-TMV-CP (TR-His-TMV-CP19). The Four-layer aggregate disk structure of TR-His-TMV-CP19 was solved.
This phenomenon showed that peptides at the C-terminus hindered the growth of high resolution crystals and the
peptides interactions at the N-terminus were attributed to the quality of TMV-CP crystals.
Conclusion: A 3.0 Å resolution macromolecular crystal of TR-His-TMV-CP19 was obtained and the corresponding
structure was solved by removing four amino acids at the C-terminus of TMV-CP and connecting His-tags at the
N-terminus of TMV-CP. It indicated that short peptides influenced the resolution of TMV-CP crystals.
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Tobacco mosaic virus (TMV) has a rod-like appearance
and consists of a single, positive strand RNA of 6395
nucleotides encapsulated in a helical virion by approxi-
mately 2130 identical coat protein (CP) subunits [1-7].
CP consists of 158 amino acids that were assembled into* Correspondence: songbaoan22@yahoo.com; fcc.syang@ gzu.edu.cn
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reproduction in any medium, provided the orfour main alpha-helices joined by a prominent loop
proximal to the axis of the virion [8-16]. TMV-CP
played an important role in the self-assembly of TMV
through an initial RNA recognition reaction that triggers
the assembly, it was believed to be necessary for virus
assembly initiation and elongation [8,17-24]. The bio-
logical physical properties of TMV-CP were often deter-
mined by the structure of TMV. The TMV structure
reported in 1986 was studied based on an electron dens-
ity map at 3.6 Å resolution by X-ray fiber diffraction [9],
and then this structure of the complete virus washis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 TMV-CP DNA fragments (1% agarose gel). (A) The whole TMV-CP fragments with BamH I and Xho I restriction enzyme cutting sites
which have been cloned in PGEX-6P-1. As shown in lane 1, amplified PCR product ran at approximately 500 bp compared with the DNA marker
(lane M). Lane 2 is a positive control with DNA template. Lane 3 is a negative control without DNA template. (B) The whole TMV-CP fragments
with Nde I and Xho I restriction enzyme cutting sites that have been cloned in pET28a. As shown in lane 1, amplified PCR product ran at
approximately 500 bp compared with the DNA marker (lane M). Lane 2 is a negative control without DNA template. Lane 3 is a positive control
with DNA template. (C) The truncation of four amino acids from the C-terminus of TMV-CP fragments with Nde I and Xho I restriction enzyme
cutting sites that have been cloned in pET28a. Lane 1 is a negative control without DNA template, whereas lane 2 is a positive control with DNA
template. Lane 3 is the amplified PCR product that ran at approximately 500 bp compared with the DNA marker (lane M).
Li et al. Virology Journal 2012, 9:279 Page 2 of 12
http://www.virologyj.com/content/9/1/279determined at 2.9 Å resolution by X-ray fiber diffraction
methods [25]. TMV-CP assembly systems, consisting of
34-subunit aggregate of TMV-CP crystallized as a dimer
of bilayer disks having 17 subunits per layer, were crys-
tallized and solved at 2.8 Å resolution [2]. The crystal-
line structure of the Four-layer aggregate of TMV-CP
was determined at 2.4 Å resolution by using X-ray dif-
fraction from crystals maintained at cryogenic tempera-
tures. This structure emphasized the importance of
water in biological macromolecular assemblies [22,23].
The circular permutants of TMV-CP were crystallized
and solved by molecular replacement at 3.0 Å resolution
by using X-ray diffraction [26]. The structure of TMV
was also obtained by using high resolution transmission
electron microscopy [27-29].Figure 2 Alignment of the TMV-CP Sequences, the identical residuesTMV-CP was usually propagated and isolated from
Nicotiana tabacum (N. tabacum) infected by TMV, and
TMV-CP existed as a number of aggregates, depending
on PH, ionic strength, temperature, protein concentra-
tion, and other factors [5,12,14-21]. At 0.1 mol/L ionic
strength orthophosphate solution and pH equal to or
greater than 8.0, TMV-CP existed as protein A or 4S
protein (a dynamic equilibrium between monomers, tri-
mers, and pentamers of TMV-CP). At 0.1 mol/L ionic
strength orthophosphate solution and pH near 7.0,
TMV-CP was transformed into the 20S aggregate form
(disks consisting of 34 monomers, also named as the
20S structure) with an admixture of 4S protein [30-33].
At 0.1 mol/L ionic strength orthophosphate solution and
pH equal to or less than 6.0, TMV-CP was completelywere marked below by an asterisk.
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disk was virtually crystallized at 1.0 mol/L ionic strength
solution and PH near 8.0 [2,3,12,17,19-21,30,31]. The
crystals of TMV-CP consisting of Four-layer aggregates
were usually obtained at 3.5–14 mg/mL protein concen-
tration (10 mmol/L orthophosphate, pH 7.2) and in
crystallization pool solutions consist of 0.2–0.3 mol/L
ammonium sulfate and 0.1 mol/L Tris at pH 8.0 for 3
wk to 4 wk at room temperature [23]. The crystals were
obtained after been equilibrated overnight against a
crystallization pool solution consisting of 0.3 mol/L am-
monium sulfate and 0.1 mol/L Tris at pH 8.0 by micro-
dialysis method [23,31-36]. The aformentioned method
of obtaining TMV-CP from TMV will take investigators
a lot of work and time, and the TMV-CP structures
obtained from TMV were aggregate forms [32-36], they
could not be easily modified. In this sense, by employing
the method of genetically engineered, recombination
TMV-CP was expressed, purified and crystallized [37-43].Figure 3 The generation of expression and purification of target prot
weight standards are shown in lane 1. Numbers on the left are the MW of
induction by IPTG that were 20 μL aliquots of whole cell lysates from 10 m
(DE3)-RIL, and pET28a-TR-His-TMV-CP19-BL21(DE3)-RIL cultures, respectively. La
from 20 μL aliquots of whole cell lysates from 1 L PGEX-6P-1-WT-GST-TMV-
corresponds to the target protein GST-TMV-CP. Lanes 7 and 8 correspond t
cell lysates from 1 L pET28a-TR-His-TMV-CP12-BL21(DE3)-RIL and pET28a-TR-H
band at position 18.5 kDa corresponds to the target protein. Lanes 9 and 1
aliquots of whole cell lysates from 1 L pET28a-TR-His-TMV-CP62-BL21(DE3)-RI
respectively. A new protein band at position 18.5 kDa corresponds to the t
purified using nickel-nitrilotriacetic acid (Ni-NTA) column. (C) WT-His-TMV-C
(D) TR-His-TMV-CP19 protein is shown in Lanes 1 and 2 purified using Ni-NT
SDS-PAGE gel filtration purified using HiLoad 16/60 Superdex 200 pg colum
purified using HiLoad 16/60 Superdex 200 pg column. (G) TR-His-MV-CP19
SDS-PAGE gel filtration purified using HiLoad 16/60 Superdex 200 pg columIn the present investigation, the genetically engineered
structure of TMV-CP was the concern: a series of the re-
combinant expression vectors contained TMV-CP genes
were constructed and transformed into E.coli, and the
recombinant protein of TMV-CP were expressed, and
3.0 Å resolution TR-His-TMV-CP19 (incorporated His-
tags at the N-terminus of TMV-CP and truncated four
amino acids at the C-terminus of TMV-CP) macromol-
ecular crystals were obtained.
Results and Discussions
Identification to Recombinant Vectors
TMV-RNA has been isolated from TMV particles (pro-
pagated in N. tabacum K326) and reverse transcribed
into cDNA by primercDNA and reverse transcriptase
(TaKaRa). The genetic fragment of wild type TMV-CP
(WT-GST-TMV-CP32, with the restriction enzymes of
BamH I/Xho I; WT-His-TMV-CP12, with the restriction
enzymes of Nde I/Xho I; ) were amplified by usingein that was analyzed using 12% SDS-PAGE. (A) Protein molecular
the standards in kDa. Lanes 1, 2, and 3 show the controls without
L PGEX-6P-1-WT-GST-TMV-CP32-BL21(DE3)-RIL, pET28a-His-TMV-CP12-BL21
nes 4, 5, and 6 correspond to the cultures after expression that were
CP32-BL21(DE3)-RIL cultures with IPTG. A new protein band at 43.5 kDa
o the cultures after expression that were from 20 μL aliquots of whole
is-TMV-CP68-BL21(DE3)-RIL culture with IPTG, respectively. A new protein
0 correspond to the cultures after expression that were from 20 μL
L and pET28a-TR-His-TMV-CP19-BL21(DE3)-RIL cultures with IPTG,
arget protein. (B) WT-GST-TMV-CP32 protein is shown in lanes 1 and 2
P12 protein is shown in Lanes 1 and 2 purified using Ni-NTA column.
A column. (E) WT-TMV-CP32 protein cleaved GST-tags is shown in 12%
n. (F) WT-His-MV-CP12 protein is shown in 12% SDS-PAGE gel filtration
protein is shown in 12%
n.
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ments, four amino acids truncated at the C-terminus of
WT-His-TMV-CP12, (TR-His-TMV-CP19), three amino
acids truncated at the N-terminus of WT-His-TMV-
CP12 and four amino acids truncated at the C-terminus
of WT-His-TMV-CP12 (TR-His-TMV-CP62), three amino
acids truncated at the N-terminus of WT-His-TMV-
CP12, and five amino acids truncated at the C-terminus
of WT-His-TMV-CP12 (TR-His-TMV-CP68), were also
amplified by PCR. Compared with the DNA marker,
all the PCR products migrated as expected at approxi-
mately 500 bp, and the PCR products were marked
as the WT-GST-TMV-CP32 (Figure1A), WT-His-TMV-
CP12 (Figure 1B), TR-His-TMV-CP19 (Figure1C), TR-
His-TMV-CP62, and TR-His -TMV-CP68 separately.
The corresponding clones were sequenced by ABI
Automatic DNA Sequence Machine, and the correct
sequences were obtained and aligned (Figure 2). The
DNA sequences of WT-GST-TMV-CP32, WT-His-TMV-
CP12, TR-His-TMV-CP19, TR-His-TMV-CP62, and TR-Figure 4 Crystallization of WT-TMV-CP32 (Cleaved GST-tags) and WT-H
octahedral WT-His-TMV-CP12 crystals grown in the crystallization room at 2
exposure in the crystallization reagent. (B), (C), and (D) Screening and optim
crystals improved, the quality of the crystals did not. Conversely, most of th
of crystallization reagents facilitated growth of WT-His-TMV-CP12 crystals. Re
crystallization reagent changed the crystallization from octahedral crystals t
cloned using the vector of PGEX-6P-1, purified using His-tags, cleaved GST-
crystallization reagents were changed, including the crystallization reagents
of the crystals or to produce a different crystal form. Only twin crystals or pHis-TMV-CP68 were similar that of WT-TMV-CP
(isolated from TMV), except for the presence of short
peptides incorporated at the N-terminal of TMV-CP in
their DNA sequences. These correct proteins were suc-
cessfully cloned to the expression host, E.coli BL21
(DE3)-RIL (TakaRa), for protein expression.
Confirmation of the Proteins Expressed and Purified by
Gel Filtration
Expressed proteins of WT-GST-TMV-CP32, WT-His-
TMV-CP12, TR-His-TMV-CP19, TR-His-TMV-CP62, and
TR-His-TMV-CP68 were initially assayed by Coomassie
brilliant blue method in a small scale experiment in
which the final volume was 10 mL(Figure 3A).The pro-
tein products including the whole cell lysates and the
target proteins were confirmed by 12% sodium dodecyl
sulfate (SDS) polyacrylamide gel electrophoresis (PAGE).
The molecular mass of WT-GST-TMV-CP32 was test by
migration at approximately 43.5 kDa (Figure 3B); the
molecular mass of WT-His-TMV-CP12 (Figure 3C),is-TMV-CP12, the scale bar represents 0.1 mm. (A) and (E) Typical
95 K. The crystals did not grow bigger regardless of the time of
ization of WT-His-TMV-CP12 crystallization. Although the size of the
e improved crystals have no diffraction. (F), (G), and (H) Optimization
sults showed that increased salt and ionic strength increased by the
o bar and lamellar crystals. (I) WT-TMV-CP32 microcrystal that was
tags by PreScission Protease. In addition, seeding tools were used and
of Hampton research, in an attempt to improve the quality and size
olycrystalline were obtained, as shown in (J), (K), and (L).
F6
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and TR-His-TMV-CP68 were test by in the same migra-
tion approximately at 18.5 kDa. The molecular mass
of WT-TMV-CP32 (WT-GST-TMV-CP32 cleaved GST-
tags) was test by migration at approximately 17.5 kDa
(Figure 3E), and the molecular mass of TR-His-TMV-
CP12 (Figure 3F) and TR-His-TMV-CP19 (Figure 3G) were
test by in the same migration at approximately 18.5 kDa.
Disk state of TR-His-TMV-CP19 in Solution
In the size exclusion chromatography, the retention vol-
ume of N-His-TMV-CP19 protein under 20 mM Sodium
Phosphate buffer and 100 mM Sodium Chloride solution
(PH 8.0) was the oligomeric state (dimmers and mono-
mers), and the retention volume of TR-His-TMV-CP19
was transformed to disks mostly after dialyzing against
0.2–0.3 mol/L ammonium sulfate and 0.1 mol/L Tris (
PH 8.0 ) solution at room temperature for more than 10
hr. The disk state of TR-His-TMV-CP19 was confirmed
by the map of SEC (Figure 6A) and Native-PAGE simul-
taneously (Figure 6B and Figure 6C).
Identification and Diffraction of Crystals
Macromolecular crystals were grown in crystallization
buffers with high levels of supersaturation, oftenFigure 5 Examples of TR-His-TMV-CP19 crystals with fused short pept
(Showed in Table 4), the scale bar represents 0.1 mm.reaching several hundred percent. WT-TMV-CP32, WT-
His-TMV-CP12, TR-His-TMV-CP62, TR-His-TMV-CP68
crystals (Figure 4) were cultured by using Index Screen
(Hampton research) and ammonium sulfate buffers.
These crystals were optimized by seeding method, but
high resolution crystals were not obtained.
On the contrary, TR-His-TMV-CP19 crystals (Figure 5)
(protein concentration: 14 mg/mL) with 3.0 Å resolution
were obtained in 0.25 mol/L ammonium sulfate and 0.1
mol/L Tris solution at 295 K, PH 7.7 (Figure 6), and the
Four-layer aggregate disk structure of TR-His-TMV-
CP19 was solved.
TMV-CP has been available as a recombinant protein
expressed in E.coli for more than 20 years [37,38]. The
incorporation of His-tags at the C-terminal of TMV-CP
has been reported recently by introducing His-tags into
TMV-CP to facilitate their purification [39]. To date,
however, no one has reported on the crystallization of
recombinant TMV-CP connecting peptides expressed in
E. coli, except on the residues of chemical modification
of TMV-CP [26,40-43]. These recombinant proteins
connecting with peptides often did not affect the bio-
logical activity of the engineered proteins, located at the
exterior of the TMV-CP disks. To obtain high resolution
crystals, the expression vectors containing TMV-CPides and truncated four amino acids from the C-terminus
Figure 6 The form of TR-His-TMV-CP19 proteins were analyzed by SEC and 17% Native-PAGE and the diffraction analysis of crystals on
proteins of TR-His-TMV-CP19 and WT-His-TMV-CP12 (A) The assembly of TR-His-TMV-CP19 was measured by Superdex 200 10/300 GL
Column, Blue line represented TR-His-TMV-CP19 dialyzed against 0.2 mol/L ammonium sulfate and 0.1 mol/L Tris solution ( PH 8.0 ) at
room temperature for 12 hr. Protein peaks were monitored by UV absorbance at wavelength of 280 nm and retention volumes corresponding
to molecular mass were recorded in 20 mM PB and 100 mM sodium chloride, the molecular mass standards were indicated on top of the figure;
Red line represents TMV-CP control which did not dialyze against, (B) the 17% Native-PAGE of WT-His-TMV-CP19. As shown in lane M. Numbers
on the left were the MW of the standards in kDa, Lanes 1, 2, correspond to the WT-His-TMV-CP19 dialyzed against 0.2 mol/L ammonium sulfate
and 0.1 mol/L Tris solution ( PH 8.0 ) at room temperature for 12 hr, (C) the 17% Native-PAGE of WT-His-TMV-CP19. As shown in lane M. Numbers
on the left were the MW of the standards in kDa, Lanes 1, 2, correspond to the WT-His-TMV-CP19 did not dialyze against the corresponding
solution, (D) X-ray crystal diffraction of WT-His-TMV-CP12 marked in Figure 5B, (E) X-ray crystal diffraction of TR-His-TMV-CP19 marked in Figure
6A, (F) X-ray crystal diffraction of TR-His-TMV-CP19 marked in Figure 6G, (G) X-ray crystal diffraction of TR-His-TMV-CP19 marked in Figure 6J, (H)
X-ray crystal diffraction of TR-His-TMV-CP19 obtained from the conditions of Figure 6J, (I) The Four-layer aggregate structure of TR-His-TMV-CP19
incorporated His-tags.
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Figure 7 Diagram showing the growth curve of the
crystallization of TR-His-TMV-CP19. The predominant species at
protein concentration conditions of 8.0–14 mg/mL at pH 6.8–7.8
with ionic strength of 0.4–1.0 are the perfect crystals, identified
as higher resolution crystals. As the pH falls below pH 7.0,
TR-His-TMV-CP19 did not grow in the form of crystals. On the
contrary, the TR-His-TMV-CP19 crystals grew with increasing protein
concentration, pH (pH 7.8–8.0), and ionic strength (0.7–1.0) of the
crystallization pool buffers. The crystals can also be harvested when
the protein concentration is 14 mg/mL because high resolution
crystals are formed at this concentration. When the crystallization
pool buffers conditions are at pH 8.5 with ionic strength of 0.7–1.0,
no high resolution crystals can be harvested.
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tempt was made to harvest the WT-His-TMV-CP12 frag-
ments by using thrombin cleavage to cleave His-tags.
His-tags were not cleaved when the proportion of
thrombin cleavage and recombinant proteins was
increased from 1:1 to 8:1. Subsequently, another genetic-















aThe WT-His-TMV-CP12 fragment was amplified by using primer1 and primer2.
bThe WT-GST-TMV-CP32 fragment was amplified by using primer3 and primer2.
cThe TR-His-TMV-CP19 fragment was amplified by using primer1and primer9.
dThe TR-His-TMV-CP62 fragment was amplified by using primer6 and primer2.
eThe TR-His-TMV-CP68 fragment was amplified by using primer6 and primer8.and expressed. Compared with His-tags, the GST-tags
were easily cleaved by PreScission Protease. The crystals
of WT-TMV-CP32 and WT-His-TMV-CP12 were grown
in ammonium sulfate buffers and commercial crystal-
lization reagents simultaneously. No high resolution
crystals were formed in the hanging drops when the
proportion of WT-TMV-CP32 to crystallization solu-
tion was 1:1. Only tiny octahedral WT-His-TMV-CP12
crystals were grown in the crystallization room at 295 K.
No matter how long the growth time was, the crystals
did not grow bigger in the crystallization buffers and
commercial crystallization reagents. To maintain the
physical properties of WT-His-TMV-CP12 according to
the crystalline structure of WT-TMV-CP (the amino
acids at the terminal of WT-TMV-CP were flexibly)
(PDB codes 1EI7 and 1VTM), three kinds of WT-His-
TMV-CP12 truncated amino acids at the C-terminal
(TR-His-TMV-CP19, TR-His-TMV-CP62, TR-His-TMV-
CP68) were constructed, expressed, purified and formed
20S disks. And then the crystals of TR-His-TMV-CP19
appeared when the protein concentration (20 mmol/L
orthophosphate and 100 mmol/L sodium chloride, pH
8.0, at 297 K for 12 hr) is 8.0–14 mg/mL and
crystallization pool solution (pH 7.7) consisting of 0.1
mol/L ammonium sulfate and 0.1 mol/L Tris at 295 K
for 24 hr. The increasing of the ionic strength (1.0) and
pH of the crystallization pool buffers resulted in the ap-
pearance of TR-His-TMV-CP19 crystals in the circum-
stance of higher protein concentration. Compared with
WT-TMV-CP, the purified protein of TR-His-TMV-CP19
was in the form of protein A (Figure 6A).
The crystals of TR-His-TMV-CP19 were obtained at
2.9–7.0 Å resolution (Figure 6E-6H) and the crystal of
WT-His-TMV-CP12 was obtained without diffraction. A
Four-layer aggregate crystal structure of TR-His-TMV-
CP19 was obtained by removing four amino acids at the








Table 2 Protein building blocks used or referenced herein
Building block Origin Abbreviation
Wild type TMV coat protein N. tabacum K326 WT-TMV-CP
a
Wild type TMV coat protein with GST tags E. coliBL21(DE3)-RIL WT-GST-TMV-CP32
b
Wild type TMV coat protein with His tags E. coliBL21(DE3)-RIL WT-His-TMV-CP12
c
Truncated 19 TMV coat protein with His tags E. coliBL21(DE3)-RIL TR-His-TMV-CP19
d
Truncated 62 TMV coat protein with His tags E. coliBL21(DE3)-RIL TR-His-TMV-CP62
e
Truncated 68 TMV coat protein with His tags E. coliBL21(DE3)-RIL TR-His-TMV-CP68
f
a The wild type TMV-CP was purified from N. tabacum K326.
bThe wild type TMV-CP expressed and purified from reconstructed prokaryotic expression vector PGEX-6P-1-TMV-CP32 that was expressed in competent cell
BL21(DE3)-RIL.
cThe wild type TMV-CP expressed and purified from reconstructed prokaryotic expression vector pET28a-TMV-CP12 that was expressed in competent cell
BL21(DE3)-RIL.
dThe truncated TMV-CP expressed and purified from reconstructed prokaryotic expression vector pET28a-TMV-CP19 that was expressed in competent cell
BL21(DE3)-RIL.
eThe truncated TMV-CP expressed and purified from reconstructed prokaryotic expression vector pET28a-TMV-CP62 that was expressed in competent cell
BL21(DE3)-RIL.
fThe truncated TMV-CP expressed and purified from reconstructed prokaryotic expression vector pET28a-TMV-CP68 that was expressed in competent cell
BL21(DE3)-RIL.
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TMV-CP19). A diagram of the growth curve of TR-His-
TMV-CP19 crystallization was drawn (Figure 7).
Compared with the crystals of WT-TMV-CP (isolated
from TMV particles), the Propagation, purification and
acquisition the macromolecular crystals of TR-His-
TMV-CP19 from E.coli were very facile process. By
investigating, it was found that the crystals of WT-His-
TMV-CP12 had close relationships with protein concen-
tration, ionic strength and PH of the solution. After
truncating four amino acids at the C-terminal of WT-
His-TMV-CP12, a Four-layer aggregate structure of TR-
His-TMV-CP19 was determined at 3.0 Å resolution by
using the technique of Hanging-drop vapor diffusion
and seeding methods, but the high resolution crystals of
WT-TMV-CP32, WT-His-TMV-CP12, TR-His-TMV-CP62,
and TR-His-TMV-CP68 did not obtain.
Conclusions
The crystallization and stability of recombinant WT-
TMV-CP were influenced by various factors such as theTable 3 The crystallization solutions of ammonium sulfate
Sample Protein concentration and buffera
WT-TMV-CP32
(cleaved GST)
8 –14 mg/mL, 20 mmol/L sodium phosphate buffer,
100 mmol/L sodium chloride, pH 8.0
WT-His-TMV-CP12 8–14 mg/mL, 20 mmol/L sodium phosphate buffer,
100 mmol/L sodium chloride, pH 8.0
TR-His-TMV-CP19 8–14 mg/mL, 20 mmol/L sodium phosphate buffer,
100 mmol/L sodium chloride, pH 8.0
TR-His-TMV-CP68 8–14 mg/mL, 20 mmol/L sodium phosphate buffer,
100 mmol/L sodium chloride, pH 8.0
TR-His-TMV-CP62 8–14 mg/mL, 20 mmol/L sodium phosphate buffer,
100 mmol/L sodium chloride, pH 8.0
a The buffers were provided with filter membrane.
b The buffers were provided with filter membrane.charge, isoelectric point, hydrophilicity of hybrid CP, and
especially the length of the amino sequence. Based on
the crystallization methods of WT-TMV-CP (isolated
from TMV particles), the crystals of TR-His-TMV-CP
(TR-His-TMV-CP19, TR-His-TMV-CP62, TR-His-TMV-
CP68) were grown in the crystallization buffers as men-
tioned above. The crystals of TR-His-TMV-CP19 were
grown by the technique of Hanging-drop vapor diffusion
and seeding methods with crystallization reagents in-
cluding several kinds of ammonium sulfate and Tris
solutions. A map of the growth curve of the
crystallization of TR-His-TMV-CP19 was drawn. In this
map, the proteins of 20s disk form of TR-His-TMV-CP19
(8.0–14 mg/mL) were firstly prepared in solutions (pH
8.0) containing 20 mmol/L orthophosphate and 100
mmol/L sodium chloride and then dialyzed against 0.2–
0.3 mol/L ammonium sulfate and 0.1 mol/L Tris solu-
tions ( PH 8.0 ) at 277 K for 12 hr. The corresponding
crystals were grown in crystallization pool solutions con-
taining 0.1–0.3 mol/L ammonium sulfate and 0.1 mol/L
Tris at pH 6.5–8.5 by the technique of Hanging-dropCrystallization bufferb Temperature
(K)
0.10–0.35 mol/L ammonium sulfate, 0.1 mol/L
Tris buffer, pH 6.5–8.5
277/295
0.10–0.35 mol/L ammonium sulfate, 0.1 mol/L
Tris buffer, pH 6.5–8.5
277/295
0.10–0.35 mol/L ammonium sulfate, 0.1 mol/L
Tris buffer, pH 6.5–8.5
277/295
0.10–0.35 mol/L ammonium sulfate, 0.1 mol/L
Tris buffer, pH 6.5–8.5
277/295
0.10–0.35 mol/L ammonium sulfate, 0.1 mol/L
Tris buffer, pH 6.5–8.5
277/295
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formed at 295 K after 1–7 d, the good macromolecular
crystals appeared under different conditions. 2.9–7.0 Å
resolution of TR-His-TMV-CP19 (concentration 14 mg/mL)
macromolecular crystals were obtained in crystallization
pool solution consisting of 0.25 mol/L ammonium
sulfate and 0.1 mol/L Tris at pH 7.7. Then, using the
same method, the crystals of WT-His-TMV-CP12 with-
out resolution and some tiny WT-TMV-CP32 crystals,
were also obtained by series of seeding experiments. It
was showed from the experiment that: the genetically
engineered proteins of TR-His-TMV-CP19 could grow
high resolution crystals. Hence, the present investigations
suggest that the C-terminal of TMV-CP was unstable for
crystallization buffer, and the amino acids at the C-
terminus were hypothesized to be very flexible. Addition-
ally, the inserted sites of short peptides of TMV-CP
could access the grown crystals. Short peptides have aTable 4 Examples of TR-His-TMV-CP19 crystals in Figure 5
Examples Protein Concentration Crystal Conditions
A 8.0 mg/mL (20 mmol/L sodium
phosphate buffer, 100 mmol/L sodium
chloride, pH 8.0)
0.1 mol/L ammonium
and 0.1 mol/L Tris/H
6.8
B 8.0 mg/mL (20 mmol/L sodium
phosphate buffer, 100 mmol/L sodium
chloride, pH 8.0)
0.1 mol/L ammonium
and 0.1 mol/L Tris/H
7.5.
C 8.0 mg/mL (20 mmol/L sodium
phosphate buffer, 100 mmol/L sodium
chloride, pH 8.0)
0.1 mol/L ammonium
and 0.2 mol/L Tris/H
7.0.
D 8.0 mg/mL (20 mmol/L sodium
phosphate buffer, 100 mmol/L sodium
chloride, pH 8.0)
0.3 mol/L ammonium
and 0.1 mol/L Tris/H
7.7.
E 8.0 mg/mL (20 mmol/L sodium
phosphate buffer, 100 mmol/L sodium
chloride, pH 8.0)
0.2 mol/L ammonium
and 0.1 mol/L Tris/H
6.8.
F 8.0 mg/mL (20 mmol/L sodium
phosphate buffer, 100 mmol/L sodium
chloride, pH 8.0)
0.2 mol/L ammonium
and 0.1 mol/L Tris/H
7.7.
G 8.0 mg/mL (20 mmol/L sodium
phosphate buffer, 100 mmol/L sodium
chloride, pH 8.0)
0.2 mol/L ammonium
and 0.1 mol/L Tris/H
6.8.
H 14 mg/mL (20 mmol/L sodium phosphate
buffer, 100 mmol/L sodium chloride, pH
8.0)
0.3 mol/L ammonium
and 0.1 mol/L Tris/H
8.0.
I 22 mg/mL (20 mmol/L sodium phosphate
buffer, 100 mmol/L sodium chloride, pH
8.0)
0.3 mol/L ammonium
and 0.1 mol/L Tris/H
7.7.
J 14 mg/mL (20 mmol/L sodium phosphate
buffer, 100 mmol/L sodium chloride, pH
8.0)
0.25 mol/L ammoniu
sulfate and 0.1 mol/L
HCl, pH 7.7.
K 22 mg/mL (20 mmol/L sodium phosphate
buffer, 100 mmol/L sodium chloride, pH
8.0)
0.2 mol/L ammonium
and 0.1 mol/L Tris/H
7.7.
L 22 mg/mL (20 mmol/L sodium phosphate
buffer, 100 mmol/L sodium chloride, pH
8.0)
0.2 mol/L ammonium
and 0.1 mol/L Tris/H
7.7.
– stand for the crystals which didn't been diffraction by X-ray methods.positive influence on the stability of the biophysical
properties of TMV-CP. Compared with WT-TMV-CP
isolated from TMV particles, this recombinant protein of
TR-His-TMV-CP19 is easy to purify and grow crystals.
Thus, the latter can be applied to structural biology and
structure-based drug design.
Methods
TMV (common strain) was isolated from N. tabacum
K326 leaves infected by TMV, which were cultivated in
the Greenhouse of Center for Research and Development
of Fine Chemicals of Guizhou University, and purified by
the method described by Gooding [44], and modified by
Shire [16,45]. TMV-CP was prepared by Scheel [18].
TMV-RNA was extracted from purified virus by treating
with phenol and SDS [46-48]. In order to obtain the gen-
eration of full-length viral cDNA sequence, TMV-RNA
was reverse transcribed using primercDNA (Table 1) in 50Crystal appearance Resolutions
sulfate
Cl, pH
The typical dodecahedral crystals were rapid




The irregular octahedral crystals were rapid




The irregular octahedral crystals were rapid




The typical octahedral crystals were rapid




The octahedral crystals were rapid growth




The octahedral crystals were rapid growth




The Octahedral crystals were rapid growth




The splintered off and crowded together
crystals were rapid growth (approximately




The hexahedral octahedral crystals were Slow




The typical octahedral crystals were Slow




The dodecahedral crystals were slow growth




The dodecahedral crystals were Slow growth
(approximately 9d) at 295 K
–
Table 5 Data collection and refinement statistics of





a, b, c (Å) 171, 311, 314
α, β, γ (°) 90, 90, 90
Resolution (Å) 50.0-3.06 (3.17-3.06)
Rsym 0.11 (0.196)
I/σ(I) 10.1 (6.4)
Completeness (%) 99.7 (99.2)
Redundancy 4.4 (3.84)
Refinement statistics






Bond lengths (Å) 0.013
Bond angles (º) 1.499
*Highest resolution shell is shown in parenthesis.
Li et al. Virology Journal 2012, 9:279 Page 10 of 12
http://www.virologyj.com/content/9/1/279mmol/L Tris at pH 8.0, 8.0 mmol/L magnesium chloride,
75 mmol/L potassium chloride, 10 mmol/L DL-Dithio-
threitol, 1.0 mmol/L dNTPs, 0.5 unit/μL AMV reverse
transcriptase (TaKaRa), and 1.0 unit/μL RNase inhibitor
(TaKaRa) for 1.5 hr at 315 K.
Using the generation of full-length viral cDNA se-
quence and the corresponding primers by the same
method, TR-His-TMV-CP19, WT-GST-TMV-CP32, WT-
His-TMV-CP12, TR-His-TMV-CP62, and TR-His-TMV-
CP68 sequences were amplified by PCR technology
(Table 2).
The dsDNA of correct length was purified and identi-
fied by 1% agarose gel electrophoresis. Both plasmid
pET28a (Novagen) and CP were digested with Nde I
(NEB, 10 units/μL)/Xho I (NEB, 10 units/μL) and cloned
into the same sites in pET28a (pET28a-WT-His-TMV-
CP12, pET28a-TR-His-TMV-CP19, pET28a-TR-His-
TMV-CP62, and pET28a-TR-His-TMV-CP68). Both plas-
mid PGEX-6P-1 (Novagen) and CP were digested with
BamH I (NEB, 10 units/μL)/Xho I (NEB, 10 units/μL)
and cloned into the same sites in PGEX-6P-1 (PGEX-
6P-1-WT-GST-TMV-CP32). Transcription reactions
were performed by using the corresponding transcrip-
tion system. E. coli BL21 (DE3)-RIL (TaKaRa) cultures
were transformed into vectors involving aforementioned
recombinant plasmid. Expression plasmids were grown
in Luria-Bertani (LB) medium containing 30 μg/mL
kanamycin at 310 K until the OD600 reached 0.65–1.0.
After cooling the cultures to 289 K, the expression prod-
uct was induced by the addition of 1.0 mmol/L IPTG,
and the culture was incubated for 16 hr. The cells were
harvested by centrifugation and resuspended in 35 mL
lysis buffer (100 mmol/L sodium chloride, 50 mmol/L
phosphate buffer, pH 8.0, 10 mmol/L ß-mercaptoetha-
nol). Then, the cells were thawed, lysed by supersonic
device, and then centrifuged at 15000 rpm for 30 min at
277 K. The supernate was then passed through 0.22 mm
syringe filters (Millipore) and loaded onto a Ni Sephar-
ose High performance column (GE Healthcare, 5mL),
washed with five column volumes of 40 mmol/L imid-
azole, and eluted with 400 mmol/L imidazole. The
N-terminal His-tags failed to cleaved with thrombin
(1.0 unit/mg) and N-terminal GST-tags was cleaved suc-
cessfully with PreScission Protease (1.0 unit/mg) by in-
cubating overnight at 277 K. The cleaved GST-tags and
uncleaved His-tags were removed by the same chelating
column, and the flow-through was concentrated in an
Amicon Ultra centrifugal filter device (Millipore) with a
10 kDa filter and then loaded onto a HiLoad 16/60
Superdex 200 pg column equilibrated in the dialysis so-
lution (20 mmol/L orthophosphate and 100 mmol/L so-
dium chloride, pH 8.0). The protein was concentrated to
5.0–25 mg/mLfor the crystallization trials by using Ami-
con Ultra centrifugal filter units (Millipore) with a 10kDa molecular weight cutoff. The target proteins were
briefly stored at 277 K.
The purification proteins were dialyzed against the
appropriate high-salt solution at room temperature to
obtain the Four-layer aggregate (20S disk) [35,36,49-52].
The 20S disk form proteins were confirmed by Size
Exclusion Chromatography (SEC) and Native-polyacrylamide
gel Electrophoresis (Native-PAGE) method. SEC was per-
formed at room temperature by using a calibrated Super-
dex 200 10/300 GL column (GE Healthcare) attached to
an AKTApurifier fast protein liquid chromatography sys-
tem (GE Healthcare). The column was equilibrated with
a solution containing 20 mM orthophosphate (pH 8.0),
100 mM NaCl solution. Molecular mass standards
(Bio-Rad) used are: Thyroglobulin (669 kDa), Ferritin
(440 kDa), BSA (67 kDa), β-lactoglobulin (35 kDa), Ribo-
nuclease A (13.7 kDa), Cytochrome (13.6 kDa), Aproti-
nin (6.51 kDa) and Vitamin B12 (1.36 kDa). Protein was
monitored by absorbance at the wavelength of 280 nm.
The crystals of purified proteins were obtained by the
technique of Hanging-drop vapor diffusion. The protein
concentration was 5.0–25 mg/mL, and the crystallization
solutions contained 0.1–0.3 mol/L ammonium sulfate
and 0.1 mol/L Tris at PH 6.5–8.5 (Table 3) for 1–7 d at
293–298 K. The crystals (Table 4) were first soaked with
cryoprotection (the reservoir solution containing an
extra 30% glycerol), and then mounted and flash-frozen
in liquid nitrogen [33,34]. Diffraction data were collected
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http://www.virologyj.com/content/9/1/279at Shanghai Synchrotron Radiation Facility beamline
17U. All the X-ray data were processed by using
HKL2000 program suite and converted to structure fac-
tors within the CCP4 program (Table 5).
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